{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T12:52:23Z","timestamp":1793105543550,"version":"4.5.0"},"reference-count":29,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,11,1]],"date-time":"2017-11-01T00:00:00Z","timestamp":1509494400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,11,1]],"date-time":"2017-11-01T00:00:00Z","timestamp":1509494400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,11,1]],"date-time":"2019-11-01T00:00:00Z","timestamp":1572566400000},"content-version":"vor","delay-in-days":730,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","resmedjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Respiratory Medicine"],"published-print":{"date-parts":[[2017,11]]},"DOI":"10.1016\/j.rmed.2017.09.003","type":"journal-article","created":{"date-parts":[[2017,9,8]],"date-time":"2017-09-08T13:32:33Z","timestamp":1504877553000},"page":"9-14","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":145,"special_numbering":"C","title":["Toxicity risk from glucocorticoids in sarcoidosis patients"],"prefix":"10.1016","volume":"132","author":[{"given":"Nauman A.","family":"Khan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher V.","family":"Donatelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adriano R.","family":"Tonelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan","family":"Wiesen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuel L.","family":"Ribeiro Neto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Debasis","family":"Sahoo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel A.","family":"Culver","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.rmed.2017.09.003_bib1","first-page":"325","article-title":"Current and emerging pharmacological treatments for sarcoidosis: a review","volume":"7","author":"Beegle","year":"2013","journal-title":"Drug Des. Devel Ther."},{"issue":"5","key":"10.1016\/j.rmed.2017.09.003_bib2","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/j.rmed.2009.12.009","article-title":"Pharmacotherapy for pulmonary sarcoidosis: a delphi consensus study","volume":"104","author":"Schutt","year":"2010","journal-title":"Respir. Med."},{"issue":"2","key":"10.1016\/j.rmed.2017.09.003_bib3","first-page":"149","article-title":"ATS\/ers\/WASOG statement on sarcoidosis. American thoracic society\/european respiratory society\/world association of sarcoidosis and other granulomatous disorders","volume":"16","author":"Hunninghake","year":"1999","journal-title":"Sarcoidosis, Vasc. Diffus. lung Dis. Off. J. WASOG\/World Assoc. Sarcoidosis Other Granulomatous Disord."},{"issue":"7","key":"10.1016\/j.rmed.2017.09.003_bib4","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1164\/rccm.200603-402OC","article-title":"Infliximab therapy in patients with chronic sarcoidosis and pulmonary involvement","volume":"174","author":"Baughman","year":"2006","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"5","key":"10.1016\/j.rmed.2017.09.003_bib5","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1183\/09031936.00000914","article-title":"Safety and efficacy of ustekinumab or golimumab in patients with chronic sarcoidosis","volume":"44","author":"Judson","year":"2014","journal-title":"Eur. Respir. J."},{"issue":"7","key":"10.1016\/j.rmed.2017.09.003_bib6","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1136\/ard.2008.092163","article-title":"Dose-related patterns of glucocorticoid-induced side effects","volume":"68","author":"Huscher","year":"2009","journal-title":"Ann. Rheum. Dis."},{"issue":"2","key":"10.1016\/j.rmed.2017.09.003_bib7","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/0002-9343(77)90233-9","article-title":"Potency and duration of action of glucocorticoids. Effects of hydrocortisone, prednisone and dexamethasone on human pituitary-adrenal function","volume":"63","author":"Meikle","year":"1977","journal-title":"Am. J. Med."},{"issue":"Supplement_1","key":"10.1016\/j.rmed.2017.09.003_bib8","doi-asserted-by":"crossref","first-page":"S8","DOI":"10.2337\/dc15-S005","article-title":"Classification and diagnosis of diabetes","volume":"38","author":"Group DC","year":"2015","journal-title":"Diabetes Care"},{"issue":"3","key":"10.1016\/j.rmed.2017.09.003_bib9","doi-asserted-by":"crossref","first-page":"2413","DOI":"10.1161\/01.CIR.101.3.329","article-title":"Essential hypertension","volume":"101","author":"Carretero","year":"2000","journal-title":"Circulation"},{"issue":"25","key":"10.1016\/j.rmed.2017.09.003_bib10","doi-asserted-by":"crossref","first-page":"3143","DOI":"10.1161\/circ.106.25.3143","article-title":"Third report of the national cholesterol education Program (NCEP) expert Panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult treatment Panel III) final report","volume":"106","author":"Cholesterol","year":"2002","journal-title":"Circulation"},{"issue":"8","key":"10.1016\/j.rmed.2017.09.003_bib11","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1002\/jbmr.5650090802","article-title":"The diagnosis of osteoporosis","volume":"9","author":"Kanis","year":"1994","journal-title":"J.\u00a0Bone Min. Res."},{"key":"10.1016\/j.rmed.2017.09.003_bib12","unstructured":"WHO. Obesity. http:\/\/www.who.int\/topics\/obesity\/en\/."},{"issue":"3","key":"10.1016\/j.rmed.2017.09.003_bib13","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1136\/thx.51.3.238","article-title":"British Thoracic Society Sarcoidosis study: effects of long term corticosteroid treatment","volume":"51","author":"Gibson","year":"1996","journal-title":"Thorax"},{"issue":"1","key":"10.1016\/j.rmed.2017.09.003_bib14","first-page":"60","article-title":"Methotrexate is steroid sparing in acute sarcoidosis: results of a double blind, randomized trial","volume":"17","author":"Baughman","year":"2000","journal-title":"Sarcoidosis Vasc. Diffus. Lung Dis."},{"issue":"5","key":"10.1016\/j.rmed.2017.09.003_bib15","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1093\/qjmed\/hcl038","article-title":"Presenting characteristics as predictors of duration of treatment in sarcoidosis","volume":"99","author":"Baughman","year":"2006","journal-title":"QJM - Mon. J. Assoc. Physicians"},{"issue":"3","key":"10.1016\/j.rmed.2017.09.003_bib16","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1378\/chest.111.3.623","article-title":"Outcome in sarcoidosis. The relationship of relapse to corticosteroid therapy","volume":"111","author":"Gottlieb","year":"1997","journal-title":"Chest"},{"key":"10.1016\/j.rmed.2017.09.003_bib17","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1111\/j.1749-6632.1986.tb18549.x","article-title":"Longitudinal study of chronic sarcoidosis with low-dose maintenance corticosteroid therapy. Outcome and complications","volume":"465","author":"Johns","year":"1986","journal-title":"Ann. N. Y. Acad. Sci."},{"issue":"3","key":"10.1016\/j.rmed.2017.09.003_bib18","first-page":"198","article-title":"Use of fluticasone in acute symptomatic pulmonary sarcoidosis","volume":"19","author":"Baughman","year":"2002","journal-title":"Sarcoidosis, Vasc. Diffus. lung Dis. Off. J. WASOG"},{"issue":"3","key":"10.1016\/j.rmed.2017.09.003_bib19","doi-asserted-by":"crossref","first-page":"e0151940","DOI":"10.1371\/journal.pone.0151940","article-title":"In-hospital disease burden of sarcoidosis in Switzerland from 2002 to 2012","volume":"11","author":"Pohle","year":"2016","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.rmed.2017.09.003_bib20","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1378\/chest.10-0413","article-title":"Sarcoidosis in black women in the United States: data from the black Women's health study","volume":"139","author":"Cozier","year":"2011","journal-title":"Chest"},{"issue":"3","key":"10.1016\/j.rmed.2017.09.003_bib21","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1002\/art.22418","article-title":"Glucocorticoids and cardiovascular events in rheumatoid arthritis: a population-based cohort study","volume":"56","author":"Davis","year":"2007","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.rmed.2017.09.003_bib22","doi-asserted-by":"crossref","first-page":"e4928","DOI":"10.1136\/bmj.e4928","article-title":"Risk of cardiovascular events in people prescribed glucocorticoids with iatrogenic Cushing's syndrome: cohort study","volume":"345","author":"Fardet","year":"2012","journal-title":"BMJ"},{"issue":"2","key":"10.1016\/j.rmed.2017.09.003_bib23","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.01290-2016","article-title":"Risk of cardiovascular disease among patients with sarcoidosis: a population-based retrospective cohort study, 1976-2013","volume":"49","author":"Ungprasert","year":"2017","journal-title":"Eur. Respir. J."},{"issue":"5","key":"10.1016\/j.rmed.2017.09.003_bib24","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/S1529-1839(04)70066-4","article-title":"Presumed ocular sarcoidosis","volume":"75","author":"Lauby","year":"2004","journal-title":"Optometry"},{"issue":"1","key":"10.1016\/j.rmed.2017.09.003_bib25","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/S0002-9394(02)01507-6","article-title":"Pathological study of cases with secondary open-angle glaucoma due to sarcoidosis","volume":"134","author":"Hamanaka","year":"2002","journal-title":"Am. J. Ophthalmol."},{"issue":"2","key":"10.1016\/j.rmed.2017.09.003_bib26","first-page":"89","article-title":"Natural and corticosteroid-induced osteoporosis in sarcoidosis: prevention, treatment, follow up and reversibility","volume":"7","author":"Rizzato","year":"1990","journal-title":"Sarcoidosis"},{"issue":"3","key":"10.1016\/j.rmed.2017.09.003_bib27","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1378\/chest.125.3.997","article-title":"Health-related quality of life of persons with sarcoidosis","volume":"125","author":"Cox","year":"2004","journal-title":"Chest"},{"issue":"4","key":"10.1016\/j.rmed.2017.09.003_bib28","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1016\/j.rmed.2015.01.019","article-title":"The effect of corticosteroids on quality of life in a sarcoidosis clinic: the results of a propensity analysis","volume":"109","author":"Judson","year":"2015","journal-title":"Respir. Med."},{"issue":"4","key":"10.1016\/j.rmed.2017.09.003_bib29","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1016\/j.ccm.2015.08.015","article-title":"Treatment of sarcoidosis","volume":"36","author":"Wijsenbeek","year":"2015","journal-title":"Clin. Chest Med."}],"container-title":["Respiratory Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0954611117303153?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0954611117303153?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,16]],"date-time":"2025-10-16T11:36:26Z","timestamp":1760614586000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0954611117303153"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,11]]},"references-count":29,"alternative-id":["S0954611117303153"],"URL":"https:\/\/doi.org\/10.1016\/j.rmed.2017.09.003","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.732308014.793568515","asserted-by":"object"}]},"ISSN":["0954-6111"],"issn-type":[{"value":"0954-6111","type":"print"}],"subject":[],"published":{"date-parts":[[2017,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Toxicity risk from glucocorticoids in sarcoidosis patients","name":"articletitle","label":"Article Title"},{"value":"Respiratory Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.rmed.2017.09.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}